Bionik Laboratories Corp Stock Probability of Future Pink Sheet Price Finishing Under -0.031
Bionik Laboratories' future price is the expected price of Bionik Laboratories instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Bionik Laboratories Corp performance during a given time horizon utilizing its historical volatility. Check out Bionik Laboratories Backtesting, Bionik Laboratories Valuation, Bionik Laboratories Correlation, Bionik Laboratories Hype Analysis, Bionik Laboratories Volatility, Bionik Laboratories History as well as Bionik Laboratories Performance.
Please specify Bionik Laboratories' target price for which you would like Bionik Laboratories odds to be computed.
Bionik |
Bionik Laboratories Target Price Odds to finish below -0.031
The tendency of Bionik Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $(0.03) or more in 90 days |
| 0.00 | 90 days | (0.03) | about 5.72 |
Based on a normal probability distribution, the odds of Bionik Laboratories to drop to $(0.03) or more in 90 days from now is about 5.72 (This Bionik Laboratories Corp probability density function shows the probability of Bionik Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Bionik Laboratories Corp price to stay between $(0.03) and its current price of $0.0 at the end of the 90-day period is about 11.06 .
Given the investment horizon of 90 days Bionik Laboratories has the beta coefficient that is very close to zero suggesting the returns on DOW JONES INDUSTRIAL and Bionik Laboratories do not appear to be very sensitive. Additionally It does not look like Bionik Laboratories' alpha can have any bearing on the current valuation. Bionik Laboratories Price Density |
| Price |
Predictive Modules for Bionik Laboratories
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bionik Laboratories Corp. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Bionik Laboratories Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bionik Laboratories is not an exception. The market had few large corrections towards the Bionik Laboratories' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bionik Laboratories Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bionik Laboratories within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.05 | |
Ir | Information ratio | 0.00 |
Bionik Laboratories Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bionik Laboratories for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bionik Laboratories Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bionik Laboratories generated a negative expected return over the last 90 days | |
| Bionik Laboratories has high historical volatility and very poor performance | |
| Bionik Laboratories has some characteristics of a very speculative penny stock | |
| Bionik Laboratories has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 1.27 M. Net Loss for the year was (10.41 M) with profit before overhead, payroll, taxes, and interest of 953.26 K. | |
| Bionik Laboratories Corp currently holds about 1.33 M in cash with (4.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19. | |
| Roughly 62.0% of the company shares are held by company insiders |
Bionik Laboratories Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bionik Pink Sheet often depends not only on the future outlook of the current and potential Bionik Laboratories' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bionik Laboratories' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.8 M | |
| Cash And Short Term Investments | 2 M |
Bionik Laboratories Technical Analysis
Bionik Laboratories' future price can be derived by breaking down and analyzing its technical indicators over time. Bionik Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Bionik Laboratories Corp. In general, you should focus on analyzing Bionik Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Bionik Laboratories Predictive Forecast Models
Bionik Laboratories' time-series forecasting models is one of many Bionik Laboratories' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Bionik Laboratories' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Bionik Laboratories Corp
Checking the ongoing alerts about Bionik Laboratories for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Bionik Laboratories Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Bionik Laboratories generated a negative expected return over the last 90 days | |
| Bionik Laboratories has high historical volatility and very poor performance | |
| Bionik Laboratories has some characteristics of a very speculative penny stock | |
| Bionik Laboratories has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 1.27 M. Net Loss for the year was (10.41 M) with profit before overhead, payroll, taxes, and interest of 953.26 K. | |
| Bionik Laboratories Corp currently holds about 1.33 M in cash with (4.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19. | |
| Roughly 62.0% of the company shares are held by company insiders |
Other Information on Investing in Bionik Pink Sheet
Bionik Laboratories financial ratios help investors to determine whether Bionik Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bionik with respect to the benefits of owning Bionik Laboratories security.